Anika Therapeutics, Inc. (ANIK) Misses Q1 EPS by 3c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $21.55 +2.08%
EPS Growth %: -125.0%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
RCBC, GASS, YSG, More
EPS Growth %: -125.0%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
RCBC, GASS, YSG, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q1 EPS of $0.14, $0.03 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $14.4 million versus the consensus estimate of $18.2 million.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
For earnings history and earnings-related data on Anika Therapeutics, Inc. (ANIK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Barrick Mining said to delay IPO of American gold business to 2027
- Chargepoint Holdings Inc. (CHPT) Tops Q2 EPS by 25c, Beats on Revenue
- Hewlett Packard Enterprise (HPE) Tops Q3 EPS by 19c; raises guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
